SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-220343
Filing Date
2020-08-14
Accepted
2020-08-14 16:07:14
Documents
3
Period of Report
2020-08-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d56707d8k.htm 8-K 19437
2 EX-3.1 d56707dex31.htm EX-3.1 26362
3 EX-3.2 d56707dex32.htm EX-3.2 101309
  Complete submission text file 0001193125-20-220343.txt   148267
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39425 | Film No.: 201105040
SIC: 2836 Biological Products, (No Diagnostic Substances)